Literature DB >> 12968925

Effects of GSM-900 microwaves on DMBA-induced mammary gland tumors in female Sprague-Dawley rats.

Rachid Anane1, Pierre-Emmanuel Dulou, Murielle Taxile, Michel Geffard, François-Lucien Crespeau, Bernard Veyret.   

Abstract

The aim of this investigation was to test the hypothesis that sub-chronic whole-body exposure to GSM-900 microwaves had an effect on tumor promotion and progression. Mammary tumors were induced by ingestion of a single 10-mg dose of 7,12-dimethylbenz(a)anthracene (DMBA) in female Sprague-Dawley rats (Ico:OFA-SD; IOPS Caw). In two independent experiments, DMBA-treated animals were divided into four groups: sham-exposed (16) and exposed (three groups of 16 animals). The specific absorption rates (SARs), averaged over the whole body, were 3.5, 2.2 and 1.4 W/kg in the first experiment (May-July) and 1.4, 0.7 and 0.1 W/kg in the second experiment (September-November). Exposure started 10 days after DMBA treatment and lasted 2 h/day, 5 days/week for 9 weeks. Animals were exposed to plane waves with the electric field parallel to the long axis of the animals. Body weight and the number, location and size of the tumors were recorded at regular intervals. Rats were killed humanely 3 weeks after the end of exposure. The results are negative in terms of latency, multiplicity and tumor volume. With regard to tumor incidence, in the first experiment there was an increase in the rate of incidence at 1.4 W/kg but less at 2.2 W/kg and none at 3.5 W/kg. Overall, these results, which are rather inconsistent, do not bring new evidence of a co-promoting effect of exposure to GSM-900 signals using the DMBA rat model.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12968925     DOI: 10.1667/rr3052

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  2 in total

Review 1.  Evaluation of carcinogenic effects of electromagnetic fields (EMF).

Authors:  Vahdettin Bayazit; Banu Bayram; Zeydin Pala; Ozkan Atan
Journal:  Bosn J Basic Med Sci       Date:  2010-08       Impact factor: 3.363

Review 2.  Review of the Evidence that Transcranial Electromagnetic Treatment will be a Safe and Effective Therapeutic Against Alzheimer's Disease.

Authors:  Gary W Arendash
Journal:  J Alzheimers Dis       Date:  2016-05-30       Impact factor: 4.472

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.